<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Ending on a Bright Note: Q122 OrthoBio Market Recap

7/14/22 9:30 AM

Q122 OrthoBio Recap Header V2Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached pre-pandemic levels.

Virtually all orthopedic/spine companies experienced the same pattern with elective procedures during the quarter. In general, elective procedure case counts were pressured in January through the beginning of February as a surge in COVID-19 cases impacted patients and contributed to staffing shortages at healthcare facilities. However, by the end of the quarter elective procedures approached or returned to pre-COVID levels.

Among the many topics covered in detail in our comprehensive Q122 OrthoBio Market Recap* are:

  • Complete Q122 OrthoBio Market Overview
  • SmartTRAK's Expert Analysis and Insights
  • All Market News including Revenues, Data, Charts and Shares
  • Notable Company-Specific Commentary
  • New Product Introductions
  • Clinical Trial Activity
  • OrthoBio M&A, Deals and Financing

Several companies now report a “backlog” of patients, which along with a generalized recovery in case volumes coinciding with the end of the pandemic, should buoy elective procedures, and in turn biologics revenue, for the next 1-2 quarters. Going forward ...

Read the entire Q122 OrthoBio Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More


SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click here.

Topics: Orthobiologics

James Petricek
Written by James Petricek

20+ years operational and management consulting experience in orthobiologics and regenerative medicine with roles in product development, marketing and business development. Prior management positions with BioMimetic Therapeutics and Synthes.

    Follow Us on Social Media

    Recent Articles